Elanco launches new PWD vaccine

Elanco Animal Health has launched a new vaccine in the UK and Ireland that it describes as a ‘major breakthrough’ in the fight against post-weaning diarrhoea (PWD).

Coliprotec F4/F18, launched on May 1, is the first single dose oral vaccine intended for active immunisation of pigs against F4- and F18-positive strains of enterotoxigenic Escherichia coli (ETEC), two significant agents of PWD.

Ciara O’Neill, Elanco’s UK and Ireland technical consultant, said the vaccine can contribute to herd health and performance by reducing both the incidence of moderate to severe PWD and the faecal shedding of these two economically damaging strains of E.coli from infected pigs.

She described the new vaccine, developed by Prevtec Microbia and distributed by Elanco in the EU, as ‘a sustainable and innovative solution to the age-old problem of post-weaning scours’.

She said: “Vets and farmers can have confidence in this new addition to their PWD toolbox, which will limit the impact of ETEC E.coli at such an important stage in pigs’ lives. The vaccine has the potential to change current practices on farm and could reduce the need for antibiotics post-weaning.”
Gaynor Hillier, Elanco’s affiliate director for the UK and Ireland, says: “As a major breakthrough in the fight against post-weaning diarrhoea in pigs, Coliprotec F4/F18 is a significant addition to our range of vaccines in the UK and Ireland.”

Get Our E-Newsletter - Pig World's best stories in your in-box twice a week
Will be used in accordance with our Privacy Policy
Share.

About The Author

Editor of Pig World and contributor to LBM’s other farming publications. Also National Pig Association webmaster. Formerly political editor at Farmers Guardian for many years. Enjoy a bit of media punditry. Brought up on a Leicestershire farm. Work from a shed in the garden in Oxfordshire. Under-9 football coach and big fan of Leicester City and Leicester Tigers. Occasional cricketer.